India markets close in 52 minutes
  • BSE SENSEX

    52,153.39
    -348.59 (-0.66%)
     
  • Nifty 50

    15,647.15
    -120.40 (-0.76%)
     
  • USD/INR

    73.9820
    +0.7120 (+0.97%)
     
  • Dow

    34,033.67
    -265.63 (-0.77%)
     
  • Nasdaq

    14,039.68
    -33.22 (-0.24%)
     
  • BTC-INR

    2,910,470.00
    -54,384.00 (-1.83%)
     
  • CMC Crypto 200

    975.90
    -16.57 (-1.67%)
     
  • Hang Seng

    28,558.59
    +121.75 (+0.43%)
     
  • Nikkei

    29,018.33
    -272.68 (-0.93%)
     
  • EUR/INR

    88.4314
    -0.3521 (-0.40%)
     
  • GBP/INR

    103.4302
    +0.1617 (+0.16%)
     
  • AED/INR

    20.1000
    +0.1960 (+0.98%)
     
  • INR/JPY

    1.4925
    -0.0042 (-0.28%)
     
  • SGD/INR

    55.2730
    +0.0300 (+0.05%)
     

Global Neuropathic Pain Epidemiology and Patient Flow Report 2021-2035

·2-min read

Dublin, May 18, 2021 (GLOBE NEWSWIRE) -- The "Global Neuropathic Pain Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Global Neuropathic Pain Epidemiology and Patient Flow Analysis - 2021, provides Neuropathic Pain epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Neuropathic Pain patients, history of the disease at the population level (Neuropathic Pain prevalence, Neuropathic Pain incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

  • Neuropathic Pain patient flow: Neuropathic Pain prevalence, diagnosed, and drug-treated patients

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries

  • Demographics: Neuropathic Pain patients by age group, gender

  • Forecast: Neuropathic Pain epidemiology forecast to 2035

The data from this research will help executives:

  • Establish basis for Neuropathic Pain market sizing, assessing market potential, and developing drug forecast models

  • Identify Neuropathic Pain patients segments through age groups, gender, and disease sub-types

  • Develop Neuropathic Pain population-based health management frameworks

  • Evaluate Neuropathic Pain market opportunities, identify target patient population

  • Align marketing decisions with the Neuropathic Pain target population

  • Communicate leadership and health authorities about your Neuropathic Pain target patient population

Key Topics Covered:

1. Research Methodology
2. Neuropathic Pain Patients Definition
3. US Neuropathic Pain Epidemiology and Patient Flow
4. Germany Neuropathic Pain Epidemiology and Patient Flow
5. France Neuropathic Pain Epidemiology and Patient Flow
6. Italy Neuropathic Pain Epidemiology and Patient Flow
7. Spain Neuropathic Pain Epidemiology and Patient Flow
8. UK Neuropathic Pain Epidemiology and Patient Flow
9. Europe Neuropathic Pain Epidemiology and Patient Flow
10. Japan Neuropathic Pain Epidemiology and Patient Flow
11. Global Neuropathic Pain Epidemiology and Patient Flow

For more information about this report visit https://www.researchandmarkets.com/r/h2jq81

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting